AKRX News 35.28 07/15/2014 04:28:55 Akorn Inc (AKRX)
Post# of 273330
Posted On: 07/15/2014 5:28:55 AM
Akorn Inc (AKRX) 35.28 $AKRX
Stocks Recover Impressively; Gap Slumps In After Hours
at Investor's Business Daily - Thu Jul 10, 4:22PM CDT
Major averages ended with modest losses Thursday, recovering impressively after an early sell-off. Wall Street was rattled early over newfound concerns about the health of European banks after Espirito Santo International, the parent company of...
Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 3:43PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) inked a non-dilutive royalty deal worth $30 million with HealthCare Royalty Partners.
Stocks Claw Way Back After Morning Sell-Off
at Investor's Business Daily - Thu Jul 10, 12:42PM CDT
Stocks continued to claw their way back from opening losses Thursday, with the indexes coming more than halfway back in early-afternoon trading. The Nasdaq and S&P 500 fell less than 0.4% and the Dow Jones industrial average was off 0.5%. Volume was...
Shares of AKRX Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 32.59% as of today's recent price of $32.55.
Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:21AM CDT
Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.
Walgreens Sees Robust Growth in June Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 5:20PM CDT
Walgreens (WAG) opened 39 new drug stores in the third-quarter of fiscal 2014 in an attempt to optimize its store footprint.
Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:00PM CDT
Teva Pharmaceutical Industries Ltd.'s (TEVA) extended-regimen oral contraceptive, Seasonique got a positive recommendation from theCommittee for Medicinal Products for Human Use.
Stocks Add To Losses; TAL Education Bucks Weakness
at Investor's Business Daily - Mon Jul 07, 12:41PM CDT
Stocks worsened a little more Monday afternoon, with techs taking the hardest hit. The Nasdaq stretched its loss to 0.7%. Solar, software and biotechs were among the day's worst-performing groups. The S&P 500 and the Dow Jones industrial average lost...
Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week
at Investor's Business Daily - Thu Jul 03, 5:26PM CDT
It was a healthy week for leaders, with more than 20% of the IBD 50 list of top-rated growth stocks pressing to new highs. Three of those staged breakouts, and nearly two-in-five on the list continued intently working on base patterns. Drugmakers...
Akorn Shares Up 40.0% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 03, 9:13AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 2 months, Akorn has returned 39.98% as of today's recent price of $34.37.
Edwards Lifesciences Monitor Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 2:00PM CDT
Edwards Lifesciences' (EW) ClearSight system is the most advanced non-invasive hemodynamic monitor that amplifies a physician's access to a patient's advanced hemodynamic parameters.
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt
PR Newswire - Wed Jul 02, 5:50AM CDT
On Tuesday, July 1, 2014, the NASDAQ Composite ended at 4,458.65, up 1.14%, the Dow Jones Industrial Average advanced 0.77%, to finish the day at 16,956.07, and the S&P 500 closed at 1,973.32, up 0.67%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index ended the day at 713.38, up 1.26%, with the index advancing 4.64% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novartis AG (NYSE: NVS), Akorn Inc. (NASDAQ: AKRX), Horizon Pharma Inc. (NASDAQ: HZNP) and Mallinckrodt PLC (NYSE: MNK). Free technical research on NVS, AKRX, HZNP and MNK can be downloaded upon signing up at:
S&P 500, Dow At New Highs; 14-Year High For Nasdaq
at Investor's Business Daily - Tue Jul 01, 4:07PM CDT
Stocks rallied Tuesday, lifting the key market averages to record or multiyear highs. The Nasdaq led with a 1.1% gain as Netflix (NFLX) surged 7%. The S&P 500 and Dow industrials added 0.7% and 0.8%, respectively, to all-time closing highs. Volume...
Stocks Rise In Strong Turnover; Netflix Soars On Upgrade
at Investor's Business Daily - Tue Jul 01, 12:22PM CDT
Buyers came into the market in spades Tuesday as growth stocks outperformed again. Several headlines fueled positive sentiment, including better than expected manufacturing data out of China and a Goldman Sachs upgrade of Netflix (NFLX). The Nasdaq...
Stocks Add To Gains; Salix, Akorn Ramp Higher
at Investor's Business Daily - Tue Jul 01, 10:52AM CDT
Stocks added to their gains and were close to session highs near Tuesday's halftime. The Nasdaq rallied 1.2% to a fresh 14-year high. Meanwhile, the S&P 500 rose 0.7% to a record high. The Dow Jones industrial average climbed 0.8%, with 28 of 30...
Akorn (AKRX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 8:13AM CDT
Akorn (AKRX) Shares March Higher, Can It Continue?
After Yesterday's Rally of 4.86% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 30, 5:28PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $31.71 to a high of $33.31. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $31.89 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Mixed In Late Trade, But Growth Stocks Outperform
at Investor's Business Daily - Mon Jun 30, 1:58PM CDT
Stocks were narrowly mixed, but firming slightly going into the final hour of trading Monday, with volume running ahead of Friday's pace. In the stock market today, the Nasdaq rose 0.4%, the S&P 500 was up 0.1% and the Dow Jones industrial average...
Nasdaq Showing Outperformance; GoPro Extends Gains
at Investor's Business Daily - Mon Jun 30, 12:32PM CDT
Major stock indexes were narrowly mixed Monday afternoon. Only the tech-heavy Nasdaq showed some life. The Nasdaq rose 0.3%, thanks in part to gains in software and chip stocks. The S&P 500 rose a fraction. The Dow Jones industrial average slipped...
Cutera, Inc. (CUTR) in Focus: Stock Adds 7.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 8:11AM CDT
Cutera, Inc. (CUTR) was a big mover last session, as the company saw its shares rise over 7% on the day.
Stocks Recover Impressively; Gap Slumps In After Hours
at Investor's Business Daily - Thu Jul 10, 4:22PM CDT
Major averages ended with modest losses Thursday, recovering impressively after an early sell-off. Wall Street was rattled early over newfound concerns about the health of European banks after Espirito Santo International, the parent company of...
Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 3:43PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) inked a non-dilutive royalty deal worth $30 million with HealthCare Royalty Partners.
Stocks Claw Way Back After Morning Sell-Off
at Investor's Business Daily - Thu Jul 10, 12:42PM CDT
Stocks continued to claw their way back from opening losses Thursday, with the indexes coming more than halfway back in early-afternoon trading. The Nasdaq and S&P 500 fell less than 0.4% and the Dow Jones industrial average was off 0.5%. Volume was...
Shares of AKRX Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 32.59% as of today's recent price of $32.55.
Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:21AM CDT
Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.
Walgreens Sees Robust Growth in June Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 5:20PM CDT
Walgreens (WAG) opened 39 new drug stores in the third-quarter of fiscal 2014 in an attempt to optimize its store footprint.
Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:00PM CDT
Teva Pharmaceutical Industries Ltd.'s (TEVA) extended-regimen oral contraceptive, Seasonique got a positive recommendation from theCommittee for Medicinal Products for Human Use.
Stocks Add To Losses; TAL Education Bucks Weakness
at Investor's Business Daily - Mon Jul 07, 12:41PM CDT
Stocks worsened a little more Monday afternoon, with techs taking the hardest hit. The Nasdaq stretched its loss to 0.7%. Solar, software and biotechs were among the day's worst-performing groups. The S&P 500 and the Dow Jones industrial average lost...
Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week
at Investor's Business Daily - Thu Jul 03, 5:26PM CDT
It was a healthy week for leaders, with more than 20% of the IBD 50 list of top-rated growth stocks pressing to new highs. Three of those staged breakouts, and nearly two-in-five on the list continued intently working on base patterns. Drugmakers...
Akorn Shares Up 40.0% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 03, 9:13AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 2 months, Akorn has returned 39.98% as of today's recent price of $34.37.
Edwards Lifesciences Monitor Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 2:00PM CDT
Edwards Lifesciences' (EW) ClearSight system is the most advanced non-invasive hemodynamic monitor that amplifies a physician's access to a patient's advanced hemodynamic parameters.
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt
PR Newswire - Wed Jul 02, 5:50AM CDT
On Tuesday, July 1, 2014, the NASDAQ Composite ended at 4,458.65, up 1.14%, the Dow Jones Industrial Average advanced 0.77%, to finish the day at 16,956.07, and the S&P 500 closed at 1,973.32, up 0.67%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index ended the day at 713.38, up 1.26%, with the index advancing 4.64% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novartis AG (NYSE: NVS), Akorn Inc. (NASDAQ: AKRX), Horizon Pharma Inc. (NASDAQ: HZNP) and Mallinckrodt PLC (NYSE: MNK). Free technical research on NVS, AKRX, HZNP and MNK can be downloaded upon signing up at:
S&P 500, Dow At New Highs; 14-Year High For Nasdaq
at Investor's Business Daily - Tue Jul 01, 4:07PM CDT
Stocks rallied Tuesday, lifting the key market averages to record or multiyear highs. The Nasdaq led with a 1.1% gain as Netflix (NFLX) surged 7%. The S&P 500 and Dow industrials added 0.7% and 0.8%, respectively, to all-time closing highs. Volume...
Stocks Rise In Strong Turnover; Netflix Soars On Upgrade
at Investor's Business Daily - Tue Jul 01, 12:22PM CDT
Buyers came into the market in spades Tuesday as growth stocks outperformed again. Several headlines fueled positive sentiment, including better than expected manufacturing data out of China and a Goldman Sachs upgrade of Netflix (NFLX). The Nasdaq...
Stocks Add To Gains; Salix, Akorn Ramp Higher
at Investor's Business Daily - Tue Jul 01, 10:52AM CDT
Stocks added to their gains and were close to session highs near Tuesday's halftime. The Nasdaq rallied 1.2% to a fresh 14-year high. Meanwhile, the S&P 500 rose 0.7% to a record high. The Dow Jones industrial average climbed 0.8%, with 28 of 30...
Akorn (AKRX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 8:13AM CDT
Akorn (AKRX) Shares March Higher, Can It Continue?
After Yesterday's Rally of 4.86% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 30, 5:28PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $31.71 to a high of $33.31. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $31.89 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Mixed In Late Trade, But Growth Stocks Outperform
at Investor's Business Daily - Mon Jun 30, 1:58PM CDT
Stocks were narrowly mixed, but firming slightly going into the final hour of trading Monday, with volume running ahead of Friday's pace. In the stock market today, the Nasdaq rose 0.4%, the S&P 500 was up 0.1% and the Dow Jones industrial average...
Nasdaq Showing Outperformance; GoPro Extends Gains
at Investor's Business Daily - Mon Jun 30, 12:32PM CDT
Major stock indexes were narrowly mixed Monday afternoon. Only the tech-heavy Nasdaq showed some life. The Nasdaq rose 0.3%, thanks in part to gains in software and chip stocks. The S&P 500 rose a fraction. The Dow Jones industrial average slipped...
Cutera, Inc. (CUTR) in Focus: Stock Adds 7.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 8:11AM CDT
Cutera, Inc. (CUTR) was a big mover last session, as the company saw its shares rise over 7% on the day.
(0)
(0)